Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Paraganglioma × Vorinostat × Clear all

Sponsor

Conditions

Lymphoma 14 Leukemia, Myeloid, Acute 11 Carcinoma, Non-Small-Cell Lung 11 Breast Neoplasms 11 Glioblastoma 9 Brain Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Lymphoma, Non-Hodgkin 7 Lymphoma, Large B-Cell, Diffuse 7 Lymphoma, Follicular 7 Leukemia 7 Multiple Myeloma 6 Lymphoma, Mantle-Cell 6 Hodgkin Disease 6 Myelodysplastic Syndromes 5 Lymphoma, T-Cell, Cutaneous 5 Lung Neoplasms 5 Gliosarcoma 5 Congenital Abnormalities 5 Recurrence 4 Neoplasms 4 Lymphoma, Large-Cell, Anaplastic 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Myelomonocytic, Acute 4 Leukemia, Monocytic, Acute 4 Leukemia, Megakaryoblastic, Acute 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia, Erythroblastic, Acute 4 Immunoblastic Lymphadenopathy 4 Breast Neoplasms, Male 4

Interventions

3-Iodobenzylguanidine 3 pazopanib 1 lutetium Lu 177 dotatate 1 guadecitabine 1 gallium Ga 68 dotatate 1 copper dotatate CU-64 1 cabozantinib 1 atezolizumab 1 Radiosurgery 1 Phenoxybenzamine 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Lutetium-177 1 Lutetium 1 Iodine-131 1 Doxazosin 1 Axitinib 1 3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡